DIN 02463261 — CERDELGA 84 MG
CERDELGA is a capsule of Eliglustat marketed by SANOFI-AVENTIS CANADA INC. The full Eliglustat monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02463261
- Brand name
- CERDELGA
- Active ingredient
- Eliglustat
- Strength
- 84 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Glucosylceramide synthase inhibitor (substrate reduction therapy)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.